Our mission is to educate dedicated physicians and biomedical scientists who will serve across all disciplines of medicine. Larner is a pillar of UVM’s research enterprise, consistently securing the majority of awards and research funding.
Recent news

Fentanyl or Ketamine? UVM Researchers Join National Study Evaluating Pain Management for Traumatic Injury

UVM Clinical Trial Leads to Better Treatment for Cystic Fibrosis Patients

All Brains Belong: Health Care for the Neurodivergent Community

Thomas Griffin, Ph.D., Visits ‘Across the Fence’ for April 7–13 National Public Health Week

Public Health Experts Discuss the Realities of the Measles Outbreak
Larner Research Highlights

UVM Cancer Center and UVM Children's Hospital Offer Promising Pediatric Oncology Trial

Fentanyl or Ketamine? UVM Researchers Join National Study Evaluating Pain Management for Traumatic Injury

R1 LARNER SPOTLIGHT: Cameron Cordero, CMB Ph.D. candidate, and Steven Roberts, Ph.D.

Larner Researchers Share Key Discoveries on Cardiovascular and Brain Health

R1 LARNER SPOTLIGHT: William Copeland, Ph.D.
Quick Links
- News and Media
- Office of Medical Communications
- Larner Medicine Newsletter and Archive
- Subscribe to Larner Medicine Newsletter!
- Vermont Medicine Magazine
- Vermont Medicine Archives
- Larner College of Medicine Blog
- Art+Science: 2023-2024 MedEd Report (Opens in Issuu)
- Graphics Toolbox
- UVM Brand Overview



Larner class of 2027 admitted student statistics
- 124 students
- 26% Vermonters
- 24% underrepresented in medicine
- 24% LGBTGQA